Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000186303PMID 2046821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.

  2009cited by this paper
• Intravenous fat tolerance test with Intralipid in chronic renal failure.

  2009cited by this paper
• Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia.

  1989cited by this paper
• Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias.

  1988cited by this paper
• Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis.

  1988cited by this paper
• Lipoproteins and apolipoproteins during the progression of chronic renal disease.

  1988cited by this paper
• Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis.

  1988cited by this paper
• Serum apolipoprotein profile of patients with chronic renal failure.

  1987cited by this paper
• Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.

  1987cited by this paper
• Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

  1986cited by this paper
• Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.

  1985cited by this paper
• Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D.

  1985cited by this paper
• Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

  1985cited by this paper
• Apoproteins B and A-I and coronary artery disease in humans.

  1984cited by this paper
• Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.

  1984cited by this paper
• Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure.

  1984cited by this paper
• Putative atherogenic factors in patients with chronic renal failure.

  1983cited by this paper
• Apoprotein A and apoprotein B in patients with chronic renal failure undergoing hemodialysis and in renal graft recipients.

  1983cited by this paper
• Accumulation of lipoprotein remnants in patients with chronic renal failure.

  1983cited by this paper
• Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia.

  1983cited by this paper
• Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal.

  1982cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.

  1982cited by this paper
• Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease.

  1982cited by this paper
• Hyperlipidemia in Children with Chronic Renal Insufficiency

  1981cited by this paper
• Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays.

  1981cited by this paper
• David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins.

  1981cited by this paper
• Quantitative determination of human apolipoprotein C-III by electroimmunoassay.

  1980cited by this paper
• Fat clearance before and after heparin in chronic renal failure--haemodialysis reduces post-heparin fractional clearance rates of intralipid.

  1980cited by this paper
• Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia.

  1980cited by this paper
• The role of hypertension in hemodialysis-associated atherosclerosis.

  1980cited by this paper
• Lipid and carbohydrate metabolism in uraemia.

  1979cited by this paper
• Heparin-released plasma lipases in chronic renal failure and after renal transplantation.

  1979cited by this paper
• Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism.

  1979cited by this paper
• Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis.

  1979cited by this paper
• Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B.

  1978cited by this paper
• Determination of glomerular filtration rate in advanced renal insufficiency.

  1978cited by this paper
• Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.

  1978cited by this paper
• Response of plasma triglycerides to dietary change in patients on hemodialysis.

  1978cited by this paper
• A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

  1978cited by this paper
• UREMIC HYPERLIPOPROTEINEMIA: CORRELATION WITH RESIDUAL RENAL FUNCTION AND DURATION OF MAINTENANCE HEMODIALYSIS

  1977cited by this paper
• Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.

  1976cited by this paper
• Determination of human apolipoprotein E by electroimmunoassay.

  1976cited by this paper
• Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.

  1976cited by this paper
• Hypertriglyceridemia in patients with chronic renal insufficiency.

  1975cited by this paper
• Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.

  1975cited by this paper
• Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

  1970cited by this paper

• Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol

  2026cites this paper
• Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis

  2024cites this paper
• Altered lipid metabolism and serum lipids in chronic kidney disease

  2022cites this paper
• HDL and Kidney Diseases.

  2022cites this paper
• Role of predictable biomarkers in early detection of cardiovascular events in Chronic Kidney Disease III and IV

  2022cites this paper
• Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus

  2021cites this paper
• Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE

  2020cites this paper
• Association of Lipoprotein and Thyroid Hormones With Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

  2020cites this paper
• Treating Dyslipidemia in Adults: An Update

  2020influential citation
• Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans.

  2019cites this paper
• A Cross-sectional Study on Association of Dyslipidaemia with Chronic Kidney Disease in a Tertiary Care Hospital in Kolkata

  2018cites this paper
• Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients

  2017cites this paper
• Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease

  2017cites this paper
• A Study of Lipid Profile in Chronic Renal Disease with Special Reference to LP ( a )

  2016cites this paper
• Monocyte Chemoattractant Protien-1 (MCP-1) and Atherosclerosis in End Stage Renal Disease Patients

  2016cites this paper
• DETERMINING THE FEASIBILITY OF THE CARDIAC REHABILITATION PARADIGM AND ITS IMPACT ON EXERCISE SELF-EFFICACY AMONG CHRONIC KIDNEY DISEASE PATIENTS: A PILOT STUDY

  2015cites this paper
• Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

  2015cites this paper
• Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction.

  2015cites this paper
• Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease

  2015cites this paper
• Variación biológica de lípidos y lipoproteínas séricas en individuos sanos y pacientes con enfermedad renal crónica terminal

  2014cites this paper
• The CKD Patient with Dyslipidemia

  2014cites this paper
• Hyperlipidemia as a Risk Factor for Progression of CKD in Nondiabetics

  2014cites this paper
• Altered Lipid Metabolism and Serum Lipids in Kidney Disease and Kidney Failure

  2013cites this paper
• Reasons for the Lack of Salutary Effects of Cholesterol-Lowering Interventions in End-Stage Renal Disease Populations

  2013cites this paper
• Nutritional Management of Maintenance Hemodialysis Patients

  2013cites this paper
• Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

  2013cites this paper
• Assesment of C- Reactive Proteins and Markers ofOxidative Stress in Patients with Chronic KidneyFailure

  2012cites this paper
• Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.

  2012cites this paper
• Statins in the management of dyslipidemia associated with chronic kidney disease

  2012cites this paper
• HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach

  2012cites this paper
• Activities of lipogenic enzymes in subcutaneous adipose tissue are not increased in patients with chronic kidney failure.

  2012cites this paper
• Effect of Exercise Therapy on Lipid Parameters in Patients with End-Stage Renal Disease on Hemodialysis

  2012cites this paper
• The lipid story in chronic kidney disease: a long story with a happy end?

  2012cites this paper
• High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.

  2012cites this paper
• Title Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease

  2012cites this paper
• Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect

  2012cites this paper
• Oxidative Stress and Inflammation in Renal Patients and Healthy Subjects

  2011influential citation
• ČESKÉ VYSOKÉ UČENÍ TECHNICKÉ V PRAZE

  2011cites this paper
• The effect of decreasing renal function on lipoprotein profiles.

  2011cites this paper
• Dyslipidaemia in patients with lupus nephritis

  2011cites this paper
• Lipoprotein Abnormalities in Patients with Atherosclerotic Renovascular Disease

  2011cites this paper
• Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.

  2011cites this paper
• Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study.

  2011cites this paper
• Increased monocyte adhesion-promoting capacity of plasma in end-stage renal disease - response to antioxidant therapy.

  2010cites this paper
• Alterations of Lipid Metabolism in Chronic Nephropathies: Mechanisms, Diagnosis and Treatment

  2010cites this paper
• Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.

  2010cites this paper
• HDL metabolism and activity in chronic kidney disease

  2010cites this paper
• Papel de las estatinas en la enfermedad renal crónica (ERC)

  2010cites this paper
• Effect of Vitamin E Supplementation on Plasma Lipid, Apolipoprotein and Lipoprotein Profiles in Patients on Peritoneal Dialysis and Hemodialysis

  2010cites this paper
• High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis

  2009cites this paper
• Low-density lipoprotein clearance in patients with chronic renal failure.

  2009cites this paper
• Lack of Association between Small Dense Low-Density Lipoprotein Levels and Coronary Artery Disease in Chronic Hemodialysis Patients

  2009cites this paper
• Ultrapure Dialysate Influences Serum Myeloperoxidase Levels and Lipid Metabolism

  2009cites this paper
• Study on Lipid Abnormalities in Chronic Renal Failure

  2009cites this paper
• Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis

  2009cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM FARMACOLOGIA RETINOL E CAROTENÓIDES EM PACIENTES HEMODIALISADOS E SEUS REFLEXOS FISIOPATOLÓGICOS

  2009cites this paper
• Valor pronóstico de las apolipoproteínas A y B en la evolución de los pacientes con enfermedad renal crónica avanzada prediálisis

  2009cites this paper
• [Prognostic value of apolipoproteins A and B in the clinical course of patients with chronic kidney disease previous to dialysis].

  2009cites this paper
• Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.

  2009cites this paper
• Prognostic value of apolipoproteins A and B in the evolution of patients with chronic kidney disease previous to dialysis

  2009cites this paper
• In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.

  2009cites this paper
• Ausência de anticorpos antilipoproteína lipase na doença de Behçet

  2009influential citation
• CHAPTER 91 – The Role of Dyslipidemias in the Progression of Chronic Kidney Disease

  2008cites this paper
• Prevalence and Possible Causes of Dyslipidemia after Pediatric Solid Organ Transplantation

  2008cites this paper
• Atherosclerosis is associated with plasminogen activator inhibitor type‐1 in chronic haemodialysis patients

  2008cites this paper
• ESTUDO DA ATIVIDADE DAS ENZIMAS NTPDase E 5'-NUCLEOTIDASE E DO PERFIL OXIDATIVO EM PACIENTES COM INSUFICIÊNCIA RENAL CRÔNICA

  2008influential citation
• Managing dyslipidemia in chronic kidney disease.

  2008cites this paper
• Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis

  2008cites this paper
• Lipoprotein metabolism and lipid management in chronic kidney disease.

  2007cites this paper
• Plasma lipoproteins in patients with chronic renal failure (CRF)

  2007influential citation
• Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.

  2007cites this paper
• Disease of the Month Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease

  2007cites this paper
• Lipoprotein metabolism in chronic renal insufficiency

  2007cites this paper
• CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Kinetic Studies of Atherogenic Lipoproteins in Hemodialysis Patients: Do They Tell Us More about Their Pathology?

  2007cites this paper
• Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients

  2007cites this paper
• Relationship between lipid profiles and kidney function in patients with type 1 diabetes

  2007cites this paper
• Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients

  2006cites this paper
• Effect of supplementation of vitamin E, vitamin C and reduced glutathione on copper ion induced lipoprotein oxidation in renal diseased patients—Anin vitro study

  2006cites this paper
• Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.

  2006cites this paper
• Non-fasting Non-High Density Lipoprotein Cholesterol (Non-HDL-C) AS A predictor of Atherosclerosis in Patients with End Stage Renal Disease on Regular Hemodialysis

  2006influential citation
• Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure

  2006cites this paper
• Mechanisms of Dyslipoproteinemias in Systemic Lupus Erythematosus

  2006cites this paper
• The frequency of high/moderate lipoprotein risk factor for coronary artery disease is significant in juvenile-onset systemic lupus erythematosus

  2005cites this paper
• Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.

  2005cites this paper
• Uremic Serum Subtraction Inhibits Apolipoprotein A-I Production by a Human Hepatoma Cell Lin &

  2005cites this paper
• Fluvastatin in the Treatment of Dyslipidemia Associated with Chronic Kidney Failure and Renal Transplantation

  2005cites this paper
• Perfil Lipídico de Pacientes Com Insuficiência Renal Crônica em Tratamento Conservador, Hemodiálise ou Diálise Peritonial

  2005cites this paper
• Insulin resistance and postprandial triglyceride levels in primary renal disease.

  2005cites this paper
• NephrologyDialysis Transplantation Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patients

  2005cites this paper
• Lipoprotein profile in limited systemic sclerosis

  2005cites this paper
• Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.

  2005cites this paper
• Lipid and Lipoprotein Ratios as Risk Factors of Atherosclerosis in Patients with Chronic Renal Insufficiency (CRI)

  2004cites this paper
• Lipids and atherosclerosis

  2004cites this paper
• Lipoprotein(a)-Associated Atherothrombotic Risk in Hemodialysis Patients

  2004cites this paper
• Serum Homocysteine , Lipoprotein ( a ) , Tumor Necrosis Factor-Alpha , Total Cholesterol and Triglyceride Levels in Hemodialysis Patients

  2004cites this paper
• Manifestations and Risk Factors of Atherosclerosis in Chronic Renal Failure

  2004cites this paper
• Lipoprotein lipase in hemodialysis patients and healthy controls : effects of heparin

  2004cites this paper
• Serum lipids in children 3 to 5 years after kidney, liver, and heart transplantation

  2004cites this paper
• Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study.

  2004cites this paper
• Effects of Atorvastatin on Lipid Profile and Non-Traditional Cardiovascular Risk Factors in Diabetic Patients on Hemodialysis

  2003cites this paper